Fosfonziale Mono, 250 mg/5 ml 5 ml 5 pcs

Phospholipids contained in the drug are chemically similar to endogenous phospholipids, but they are much higher in content of polyunsaturated (essential) fatty acids: These high-energy molecules are embedded mainly in the structures of cell membranes and facilitate repair of damaged liver tissue.

Indications

Fatty liver degeneration, acute and chronic hepatitis, liver cirrhosis, hepatic coma and precoma, pre- and postoperative treatment for surgical interventions in the hepatobiliary zone, toxic liver damage;
Toxicosis of pregnancy;
Psoriasis (as an adjuvant therapy);
Radiation syndrome.

Pharmacological effect

The phospholipids contained in the preparation are similar in chemical structure to endogenous phospholipids, but far exceed them in the content of polyunsaturated (essential) fatty acids: These high-energy molecules are embedded primarily in the structures of cell membranes and facilitate the restoration of damaged liver tissue.

Special instructions

Only use a clear solution!

Caution: The solution contains benzyl alcohol. For intravenous use only.

Active ingredient

Phospholipids

Composition

1 ampoule contains:

Active ingredient:

Phospholipids (Lipoid C 100*) – 266.00 mg, in terms of phosphatidylcholine – 250.00 mg.

Excipients:

Benzyl alcohol – 45.00 mg,

Deoxycholic acid – 126.50 mg,

Sodium hydroxide – 13.40 mg,

Sodium chloride – 12.00,

Riboflavin – no more than 0.50 mg,

Water for injections – up to 5 ml.

*Lipoid C 100 contains no more than 0.25% α-tocopherol and no more than 0.2% ethanol.

Pregnancy

During pregnancy, due to the presence of benzyl alcohol in the drug, which can penetrate the placental barrier (the use of drugs containing benzyl alcohol in newborns born at term or premature newborns was associated with the development of dyspnea syndrome with a fatal outcome), the use of the drug is possible only in cases where the expected benefit to the mother outweighs the potential risk to the fetus.

Contraindications

Hypersensitivity to the components of the drug;

Soy intolerance;

Children’s age up to 12 years.

With caution:

Pregnancy;

Children over 12 years of age.

Side Effects

From the gastrointestinal tract: discomfort in the epigastric region, loose stools, nausea, gastralgia.

Interaction

Interactions with other drugs have not been studied.

The drug is incompatible with electrolyte solutions.

Overdose

There were no reports of overdose.

Storage conditions

At temperatures from 2 °C to 8 °C in manufacturer’s packaging.

Shelf life

2 years.

Manufacturer

Grotex LLC, Russia